Atlas Trials

TrippBio, Inc.

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch TrippBio, Inc.

RecordFirmDate
A Relative Bioavailability Study With a Novel PanCytoVir™ Oral Suspension (100 mg/ml) (NCT06025344)TrippBio, Inc.2024-09-01
An Evaluation of the Effect of Food on the PK of a Novel PanCytoVir™ Suspension (100mg/ml), in Healthy, Adult Volunteers (NCT06025318)TrippBio, Inc.2024-09-01
A Study to Evaluate the Efficacy of PanCytoVir™ for the Treatment of Non-Hospitalized Patients With COVID-19 Infection (NCT05442983)TrippBio, Inc.2022-07-12

Track TrippBio, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.